Form 4: HeartBeam Director Richard Ferrari Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Richard Ferrari reports acquisition and disposal of HeartBeam, Inc. stock and stock units.
Summary
- Richard Ferrari, a director of HeartBeam, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On June 12, 2024, Ferrari acquired 44,247 shares of common stock at $0 and disposed of 149,724 restricted stock units (RSUs).
- Following these transactions, Ferrari directly owns 27,272 shares underlying options with an exercise price of $0.28, 181,818 shares underlying options with an exercise price of $2.5, and indirectly owns 65,653 shares through the Ferrari Living Trust.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be an indicator of management's confidence in the company's future prospects.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in the financial industry to gauge the sentiment of company leadership.
- Comparing the size and frequency of these transactions to those of directors at similar companies (e.g., other small-cap medical device companies) can provide context.
- For example, directors at companies like iRhythm Technologies or BioTelemetry (prior to its acquisition) also regularly file Form 4s, and analyzing the patterns of their transactions can offer a benchmark.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company directors as an indicator of confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/12/2020 | Date of grant for options to buy common stock at $0.28, with vesting starting on this date. |
| 06/12/2024 | Date of transaction: acquisition of 44,247 shares and disposal of 149,724 RSUs. |
| 06/19/2024 | Date of signature for the Form 4 filing. |
| 06/12/2025 | Date when 100% of the RSUs shall vest, or the date of the Issuer's 2025 annual meeting of stockholders, whichever is earlier. |
| 05/12/2030 | Expiration date for options to buy common stock at $0.28. |
| 06/15/2031 | Expiration date for options to buy common stock at $2.5. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.